30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
The CDKN2A(P16) positivity rate is almost 100% in sarcomatoid mesothelioma. In contrast, approximately 50% of patients have heterozygous or heterozygous deletions of NF2. Abnormalities in the BAP1 and CDKN2A(P16) genes do not have 100% diagnostic specificity for mesothelioma, but are useful in the differential diagnosis of mesothelioma from benign pleural lesions.